Global Latent Tuberculosis Infection (LTBI) Testing Market 2020 by Company, Type and Application, Forecast to 2025

  • receipt Report ID : 118973
  • calendar_today Published On: Sep, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Latent Tuberculosis Infection (LTBI) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Latent Tuberculosis Infection (LTBI) Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 1593.2 million by 2025, from USD 1301 million in 2019.

Market segmentation

Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Latent Tuberculosis Infection (LTBI) Testing market has been segmented into Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.

Breakdown by Application, Latent Tuberculosis Infection (LTBI) Testing has been segmented into Hospitals and Clinics, Diagnostic Laboratories, Others, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Latent Tuberculosis Infection (LTBI) Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Latent Tuberculosis Infection (LTBI) Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Latent Tuberculosis Infection (LTBI) Testing market.

For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Latent Tuberculosis Infection (LTBI) Testing Market Share Analysis

Latent Tuberculosis Infection (LTBI) Testing competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Latent Tuberculosis Infection (LTBI) Testing revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Latent Tuberculosis Infection (LTBI) Testing revenue and market share for each player covered in this report.

The major players covered in Latent Tuberculosis Infection (LTBI) Testing are: Qiagen, Thermo Fisher Scientific, Sanofi, Oxford Immunotec, Bio-Rad Laboratories, Par Sterile, etc. Among other players domestic and global, Latent Tuberculosis Infection (LTBI) Testing market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

Qiagen

Thermo Fisher Scientific

Sanofi

Oxford Immunotec

Bio-Rad Laboratories

Par Sterile

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

Tuberculin Skin Test (TST)

Interferon Gamma Released Assay (IGRA)

Market segment by Application, can be divided into

Hospitals and Clinics

Diagnostic Laboratories

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Latent Tuberculosis Infection (LTBI) Testing

1.2 Classification of Latent Tuberculosis Infection (LTBI) Testing by Type

1.2.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type in 2019

1.2.3 Tuberculin Skin Test (TST)

1.2.4 Interferon Gamma Released Assay (IGRA)

1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market by Application

1.3.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Hospitals and Clinics

1.3.3 Diagnostic Laboratories

1.3.4 Others

1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

1.5 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (2015-2020)

1.7 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

1.7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

1.7.3 Asia Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

1.7.4 South America Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)

2 Company Profiles

2.1 Qiagen

2.1.1 Qiagen Details

2.1.2 Qiagen Major Business

2.1.3 Qiagen SWOT Analysis

2.1.4 Qiagen Product and Services

2.1.5 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.2 Thermo Fisher Scientific

2.2.1 Thermo Fisher Scientific Details

2.2.2 Thermo Fisher Scientific Major Business

2.2.3 Thermo Fisher Scientific SWOT Analysis

2.2.4 Thermo Fisher Scientific Product and Services

2.2.5 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.3 Sanofi

2.3.1 Sanofi Details

2.3.2 Sanofi Major Business

2.3.3 Sanofi SWOT Analysis

2.3.4 Sanofi Product and Services

2.3.5 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.4 Oxford Immunotec

2.4.1 Oxford Immunotec Details

2.4.2 Oxford Immunotec Major Business

2.4.3 Oxford Immunotec SWOT Analysis

2.4.4 Oxford Immunotec Product and Services

2.4.5 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.5 Bio-Rad Laboratories

2.5.1 Bio-Rad Laboratories Details

2.5.2 Bio-Rad Laboratories Major Business

2.5.3 Bio-Rad Laboratories SWOT Analysis

2.5.4 Bio-Rad Laboratories Product and Services

2.5.5 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

2.6 Par Sterile

2.6.1 Par Sterile Details

2.6.2 Par Sterile Major Business

2.6.3 Par Sterile Product and Services

2.6.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Players (2015-2020)

3.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Latent Tuberculosis Infection (LTBI) Testing Players Market Share

3.3.2 Top 10 Latent Tuberculosis Infection (LTBI) Testing Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Countries (2015-2020)

4.2 North America Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Countries (2015-2026)

4.3 United States Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

4.4 Canada Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

4.5 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Countries (2015-2020)

5.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Countries (2015-2026)

5.3 Germany Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

5.4 France Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

5.5 UK Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

5.6 Russia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

5.7 Italy Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (2015-2020)

6.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Regions (2015-2026)

6.3 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

6.4 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

6.5 Korea Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

6.6 India Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

6.7 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Countries (2015-2020)

7.2 South America Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

7.4 Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Regions (2015-2020)

8.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

8.4 UAE Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

8.5 Egypt Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

8.6 South Africa Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Type (2015-2025)

9.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)

9.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2020-2025)

9.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Type (2015-2025)

9.2.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2015-2020)

9.2.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Application (2015-2025)

10.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

10.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Application (2020-2025)

10.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Application (2015-2025)

10.2.1 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2015-2020)

10.2.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Latent Tuberculosis Infection (LTBI) Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Regions (2015-2020)

Table 7. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions (2020-2025)

Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Estimation in Various Scenarios in 2020

Table 10. Qiagen Corporate Information, Location and Competitors

Table 11. Qiagen Major Business

Table 12. Qiagen Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 13. Qiagen SWOT Analysis

Table 14. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 15. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 16. Thermo Fisher Scientific Corporate Information, Location and Competitors

Table 17. Thermo Fisher Scientific Major Business

Table 18. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2018-2019)

Table 19. Thermo Fisher Scientific SWOT Analysis

Table 20. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 21. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 22. Sanofi Corporate Information, Location and Competitors

Table 23. Sanofi Major Business

Table 24. Sanofi Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 25. Sanofi SWOT Analysis

Table 26. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 27. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 28. Oxford Immunotec Corporate Information, Location and Competitors

Table 29. Oxford Immunotec Major Business

Table 30. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 31. Oxford Immunotec SWOT Analysis

Table 32. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 33. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 34. Bio-Rad Laboratories Corporate Information, Location and Competitors

Table 35. Bio-Rad Laboratories Major Business

Table 36. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 37. Bio-Rad Laboratories SWOT Analysis

Table 38. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 39. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 40. Par Sterile Corporate Information, Location and Competitors

Table 41. Par Sterile Major Business

Table 42. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)

Table 43. Par Sterile SWOT Analysis

Table 44. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions

Table 45. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 46. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Players (2015-2020)

Table 47. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players (2015-2020)

Table 48. Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) in Japan (2015-2020)

Table 49. Key Players Latent Tuberculosis Infection (LTBI) Testing Revenue Share in Japan (2015-2020)

Table 50. North America Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2015-2020)

Table 51. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Table 52. North America Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2020-2026)

Table 53. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2020-2026)

Table 54. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2015-2020)

Table 55. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Table 56. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2020-2026)

Table 57. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2020-2026)

Table 58. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2015-2020)

Table 59. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Table 60. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2020-2026)

Table 61. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2020-2026)

Table 62. South America Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2015-2020)

Table 63. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Table 64. South America Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2020-2026)

Table 65. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2020-2026)

Table 66. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2015-2020)

Table 67. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)

Table 68. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Countries (2020-2026)

Table 69. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2020-2026)

Table 70. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Type (2015-2020)

Table 71. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2015-2020)

Table 72. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Type (2020-2025)

Table 73. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2020-2025)

Table 74. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Type (2015-2020)

Table 75. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2015-2020)

Table 76. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Type (2020-2025)

Table 77. Japan Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2020-2025)

Table 78. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Application (2015-2020)

Table 79. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2015-2020)

Table 80. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Application (2020-2025)

Table 81. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2020-2025)

Table 82. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Application (2015-2020)

Table 83. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2015-2020)

Table 84. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Application (2020-2025)

Table 85. Japan Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2020-2025)

Table 86.List of Figures

Table 87. Latent Tuberculosis Infection (LTBI) Testing Picture

Table 88. Global Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type in 2019

Table 90. Tuberculin Skin Test (TST) Picture

Table 91. Interferon Gamma Released Assay (IGRA) Picture

Table 92. Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application in 2019

Table 93. Hospitals and Clinics Picture

Table 94. Diagnostic Laboratories Picture

Table 95. Others Picture

Table 96. Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2025) (USD Million)

Table 97. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Regions (2015-2025)

Table 98. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Regions in 2019

Table 99. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions (2020-2025)

Table 100. North America Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 101. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 102. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 103. South America Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 104. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2015-2025)

Table 105. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players in 2019

Table 106. Global Top 5 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in 2019

Table 107. Top 10 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in Global Market in 2019

Table 108. Global Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) by Type (2015-2025)

Table 109. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Application (2015-2025)

Table 110. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries (2015-2025)

Table 111. North America Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries in 2019

Table 112. United States Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 113. Canada Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 114. Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 115. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries (2015-2025)

Table 116. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries in 2019

Table 117. Germany Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 118. France Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 119. Russia Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 120. Italy Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 121. Spain Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 122. UK Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 123. Asia Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries (2015-2025)

Table 124. Asia Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries in 2019

Table 125. China Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 126. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 127. Korea Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 128. India Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 129. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 130. South America Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries (2015-2025)

Table 131. South America Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries in 2019

Table 132. Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 133. Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 134. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries (2015-2025)

Table 135. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Share by Countries in 2019

Table 136. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 137. UAE Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 138. Egypt Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 139. South Africa Latent Tuberculosis Infection (LTBI) Testing Market Size (USD Million) and Forecast (2015-2025)

Table 140. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2015-2020)

Table 141. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2015-2020)

Table 142. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2015-2020)

Table 143. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2015-2020)